ERBB2 and cancer: In our study, expression of the SLC3A2-NRG1 fusion gene increased cancer cell proliferation in vitro and in vivo through ERBB2 and ERBB3 heterocomplexes (Figure 2A, 2B, Figure 4, and Figure 5).